WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 1 to 25 of about 5157

Website Changes

03/02/2021

The UCLA Brain Tumor Center will host part two of its Brain Tumor Virtual Conference on Friday, March 12th

02/28/2021

02/21/2021

The addition of chloroquine and bevacizumab to standard radiochemotherapy for recurrent glioblastoma multiforme

02/20/2021

Phase I trial of intranasal NEO100, highly purified perillyl alcohol, in adult patients with recurrent glioblastoma

02/19/2021

Setting international standards in analyzing patient-reported outcomes and QOL endpoints

02/16/2021

Are you Considering Optune Therapy for GBM?

02/16/2021

New zebrafish model could help advance glioblastoma multiforme research

02/16/2021

Brain tumor study reveals surprising gene deletion and method to overcome drug resistance

02/15/2021

The effects of releasing early results from ongoing clinical trials

02/12/2021

Sydney researchers identify/advance potential revolutionary new drug treatment for fatal childhood cancer

02/09/2021

New combination treatment approach improves overall survival in mice with glioblastoma

02/06/2021

GammaTile webinar posted to our video library!

02/06/2021

Amazon Smile Fundraiser! Action Required!

02/04/2021

Musella Foundation awards two brain tumor research grants!

02/02/2021

First Glioblastoma Patient Dosed in Phase 2 Trial Testing PVSRIPO Plus Keytruda

02/01/2021

Very Low Mutation Burden Is a Feature of Inflamed Recurrent Glioblastomas Responsive to Cancer Immunotherapy

01/29/2021

Mebendazole and temozolomide in patients with newly diagnosed high-grade gliomas: results of a phase 1 clinical trial

01/27/2021

Imvax Announces Publication of Phase 1b Clinical Trial of IGV-001 for Patients with Newly Diagnosed Glioblastoma in Clinical Cancer Research

01/27/2021

Learn More About GammaTile® Therapy, Surgically Targeted Radiation Therapy For Brain Tumors, At Patient Education Event On Thursday, February 4

01/26/2021

NEW MAGNETIC RESONANCE IMAGING (MRI) TECHNIQUE UNCOVERS PATHOPHYSIOLOGICAL PROCESS TO HELP EARLY DETECTION OF RECURRENT GLIOBLASTOMA

01/23/2021

Targepeutics Receives Orphan Drug Designation for Lead Drug Targeting Malignant Glioma

01/23/2021

Outcomes and Patterns of Care in Elderly Glioblastoma Multiforme Patients: A Population-Based Study of the National Cancer Database

01/22/2021

The Role of Temozolomide in Patients With Newly Diagnosed Wild-Type IDH, Unmethylated MGMTp Glioblastoma During the COVID-19 Pandemic

01/21/2021

Brain Cancer Advocate Al Musella Joins Childhood Cancer Foundation Board of Directors

01/16/2021

Body mass index as an independent prognostic factor in glioblastoma